5:45 PM
 | 
Dec 02, 2013
 |  BC Extra  |  Politics & Policy

FDA releases three guidances on compounding

FDA's Center for Drug Evaluation and Research (CDER) released three draft guidances on compounding less than a week after President Obama signed into law the Drug Quality and Security Act, which allows voluntary oversight of compounding pharmacies by FDA and creates an electronic, unit-level system for tracking and tracing pharmaceutical products. The first guidance describes...

Read the full 260 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >